Poly Medicure
add_icon

Poly Medicure

1,278.50
-33.80
(-2.58%)
Market Cap
12,958.81 Cr
PE Ratio
38.20
Volume
86,786.00
Day High - Low
1,315.50 - 1,276.40
52W High-Low
2,937.60 - 1,225.10
ann
There are new updates from the company19 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,958.81 Cr
EPS
34.13
PE Ratio
38.20
PB Ratio
4.55
Book Value
287.92
EBITDA
542.00
Dividend Yield
0.27 %
Industry
Healthcare
Return on Equity
12.24
Debt to Equity
0.08
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+60.00 %
+60.00 %
Hold
Hold+40.00 %
+40.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Poly Medicure Limited announces one-on-one virtual investor meeting with Avendus Spark scheduled for March 19, 2026 at 05:00 PM under SEBI Regulation 30 compliance.
neutral
Poly Medicure has shared an updated investor presentation with stock exchanges, highlighting its 15 manufacturing plants and annual capacity of 1.8 billion devices.
neutral
Poly Medicure Limited confirms no deviation in utilization of Rs 99,999.98 lakh QIP proceeds for quarter ended December 31, 2025, with funds allocated across manufacturing, acquisitions, and corporate purposes.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,278.50
#1 12,958.81
#5 38.20
#1 1,759.00
#6 22.62
#1 339
#3 -16.90
43.63
191.30
1,017.84
50.89
408.40
32.64
30
-5.66
46.78
180.63
992.78
43.71
242.40
24.12
25
-58.33
42.07
468.00
828.11
42.98
186.60
40.62
20
-
47.15
400.00
693.47
53.41
0.00
-
0
-67.50
24.35
145.21
645.47
#1 21.53
335.90
45.66
47
-127.80
44.97
408.00
489.70
24.27
67.10
13.15
18
4.44
30.96
230.00
437.92
27.19
136.30
#1 107.77
16
-
48.60
276.45
360.40
44.08
111.80
-
8
-
45.79
259.25
259.25
24.03
122.10
19.24
1
#1 232.14
42.07

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
22.62 %
Net Income Growth
31.09 %
Cash Flow Change
-9.64 %
ROE
-30.34 %
ROCE
-30.22 %
EBITDA Margin (Avg.)
6.13 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
137
155
159
180
166
179
185
178
175
203
209
221
223
237
238
266
254
284
300
316
335
352
357
393
402
447
448
467
447
479
522
Expenses
103
116
125
139
125
132
135
131
125
143
146
159
157
173
179
202
202
210
214
224
234
253
249
282
281
305
310
321
298
329
389
EBITDA
35
39
35
41
41
47
50
47
50
60
63
63
66
64
59
64
51
74
86
92
101
99
108
112
121
142
138
146
149
150
132
Operating Profit %
23 %
23 %
20 %
20 %
23 %
24 %
25 %
23 %
27 %
28 %
28 %
25 %
26 %
23 %
22 %
22 %
19 %
24 %
25 %
27 %
27 %
25 %
27 %
26 %
27 %
27 %
27 %
27 %
26 %
26 %
21 %
Depreciation
9
9
10
10
10
10
11
10
11
11
13
13
13
14
14
14
14
14
14
15
16
16
16
16
20
21
21
21
23
25
29
Interest
4
7
-1
2
3
2
5
8
3
3
5
-2
3
0
-1
2
1
0
5
2
3
2
4
3
3
3
3
2
3
3
6
Profit Before Tax
22
23
26
30
28
36
34
29
36
46
46
52
50
50
46
49
36
59
67
75
83
81
88
93
99
118
113
123
123
122
98
Tax
9
9
10
8
8
7
9
6
10
11
11
13
13
12
11
13
9
16
17
16
20
19
23
24
24
31
28
31
30
30
27
Net Profit
13
15
16
22
20
28
25
23
27
35
35
39
38
38
35
36
27
44
50
59
63
62
65
68
74
87
85
92
93
92
71
EPS in ₹
1.50
1.65
1.82
2.44
2.24
3.22
2.83
2.57
3.03
3.97
4.00
4.26
3.92
3.99
3.60
3.77
2.81
4.53
5.21
6.13
6.54
6.48
6.78
7.12
7.71
9.01
8.48
8.92
9.19
9.06
7.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
364
387
457
565
654
767
1,224
1,377
1,577
1,859
3,193
Fixed Assets
166
182
207
265
306
363
426
488
635
867
1,084
Current Assets
160
171
205
255
302
318
704
783
807
842
1,917
Capital Work in Progress
10
14
20
18
19
25
21
43
78
76
101
Investments
0
0
3
17
8
25
354
346
126
167
1,077
Other Assets
189
191
227
264
321
354
422
499
738
749
930
Total Equity & Liabilities
364
387
457
565
654
767
1,224
1,377
1,577
1,859
3,193
Current Liabilities
113
109
114
123
154
197
171
227
293
351
370
Non Current Liabilities
55
50
72
104
119
135
87
63
42
37
57
Total Equity
196
229
272
338
381
435
966
1,088
1,242
1,470
2,766
Reserve & Surplus
174
207
227
294
337
391
918
1,040
1,194
1,422
2,715
Share Capital
22
22
44
44
44
44
48
48
48
48
51

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
0
3
1
1
0
3
-1
5
-3
Investing Activities
-59
-31
-56
-88
-101
-110
-436
-85
-179
-241
-1,194
Operating Activities
63
63
56
75
107
131
119
124
191
266
240
Financing Activities
-6
-31
-0
16
-5
-21
317
-35
-13
-20
951

Share Holding

% Holding
Feb 2021
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
44.88 %
44.88 %
44.77 %
44.77 %
44.76 %
44.66 %
53.34 %
53.33 %
53.33 %
53.31 %
53.31 %
53.16 %
53.16 %
53.15 %
66.03 %
62.56 %
62.56 %
62.44 %
62.44 %
62.44 %
62.42 %
62.42 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
14.49 %
0.00 %
12.38 %
9.91 %
11.10 %
11.87 %
12.33 %
11.46 %
11.41 %
9.77 %
9.40 %
DIIs
1.83 %
1.92 %
2.68 %
2.73 %
2.86 %
3.18 %
3.10 %
3.20 %
3.38 %
3.68 %
4.25 %
5.15 %
5.28 %
7.22 %
9.35 %
12.48 %
12.33 %
11.66 %
11.96 %
11.72 %
13.54 %
13.84 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.24 %
15.11 %
14.24 %
13.69 %
13.24 %
12.32 %
11.93 %
11.20 %
11.18 %
11.12 %
11.10 %
11.35 %
11.38 %
11.34 %
11.37 %
10.70 %
10.14 %
10.55 %
11.08 %
11.37 %
11.25 %
11.30 %
Others
37.06 %
38.10 %
38.30 %
38.81 %
39.14 %
39.84 %
31.63 %
32.27 %
32.11 %
31.90 %
31.34 %
15.85 %
30.17 %
15.92 %
3.36 %
3.16 %
3.10 %
3.03 %
3.07 %
3.07 %
3.02 %
3.04 %
No of Share Holders
0
19,187
21,531
35,922
33,678
35,166
33,831
33,296
34,239
35,393
36,141
34,649
36,053
36,712
36,852
40,516
38,352
60,686
65,583
71,142
64,400
67,750

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 2.5 2 2 2 2.5 2.5 3 3 3.5 0.00
Dividend Yield (%) 1 0.91 0.86 0.24 0.26 0.27 0.19 0.13 0.27 0.00

Announcements

Poly Medicure Limited Has Informed The Exchange About Investors/Analysts Call/Meet On 19Th March 202619 hrs ago
Poly Medicure Limited Has Informed The Exchange About Investors/Analysts Call/Meet On 18Th March 20262 days ago
Poly Medicure Limited Has Informed The Exchange About Investors/Analysts Call/Meet On 09Th March 2026 And 10Th March 2026.5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Intimation Of Analysts/Investors Meet To Be Held On 9Th And 10Th March 20269 days ago
Intimation Of Analysts/Investors Meet To Be Held On 6Th March 202610 days ago
Intimation Of Analysts/Investors Call To Be Held On 02Nd March 2026Feb 28, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 13, 2026
Statement Of Deviation And Variation For The Quarter Ended 31St December 2025Feb 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Grant Of 2000 Stock Options Under ESOS 2020 Of The Company.Feb 05, 2026
Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2025.Feb 05, 2026
Board Meeting Outcome for Otcome Of Board Meeting Held On Today I.E. 05Th February 2026Feb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 31, 2026
Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 05Th February 2026 For Consider And Approve The Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended On 31St December 2025.Jan 29, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Clarification On Increase In VolumeJan 07, 2026
Clarification sought from Poly Medicure LtdJan 07, 2026
Closure of Trading WindowDec 29, 2025
Investors/Analysts Virtual CallDec 18, 2025
Intimation Of Investors/Analyst Virtual CallsNov 22, 2025
Intimation Of Investors/Analyst Virtual Call On 24Th November 2025Nov 20, 2025
Intimation Of Investotrs/Analyst Virtual Call On 24Th November 2025Nov 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Statement Of Deviation & Variation For The Quarter Ended 30Th September 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Investor/Analyst CallsNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Declaration Of Unaudited Financial Results For The Second Quarter And Half Year Ended For 30Th September 2025.Nov 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Hold Today I.E. 08Th November 2025 For Declaration Of Unaudited Financial Results(Standalone & Consolidated) For The Second Quarter And Half Year Ended 30Th September 2025 And For Other Businesses ItNov 08, 2025
Announcement Under Regulation 30 (LODR)-Updates On AcquisitionNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Board Meeting Intimation for Notice Of Board Meeting To Be Held On 08Th November 2025.Oct 31, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Transcript Of Investors/Analysts Conference Call Held On 25Th September 2025.Oct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Closure of Trading WindowSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationSep 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Sep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationSep 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
449
-0.05%
-0.09%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
0.41%
43
-0.08%
-0.13%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
18
-0.05%
-0.09%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.08%
-9
-0.02%
-0.04%
DSP Nifty 500 Index Fund Direct-Growth
0.02%
-1
-0.01%
0.02%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
1
0.00%
-0.01%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
0
0.00%
-0.06%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
0
0.00%
-0.06%
Bank of India ELSS Tax Saver Direct-Growth
0.00%
0
0.00%
0.00%
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bank of India Small Cap Fund Direct-Growth
0.16%
0
0.00%
-0.26%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
0
0.00%
-0.94%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
-0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
0
0.00%
-0.06%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth
1.21%
0
0.00%
-0.26%
Edelweiss Business Cycle Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
0
0.00%
-0.06%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
0
0.00%
-0.06%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
0
0.00%
-0.01%
HDFC BSE 500 Index Fund Direct - Growth
0.03%
0
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.25%
0
0.00%
-0.06%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.06%
0
0.00%
-0.02%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.02%
0
0.00%
-0.01%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.25%
0
0.00%
-0.06%

Technical Indicators

RSI(14)
Neutral
43.63
ATR(14)
Less Volatile
65.25
STOCH(9,6)
Neutral
53.84
STOCH RSI(14)
Neutral
64.59
MACD(12,26)
Bullish
15.12
ADX(14)
Strong Trend
28.47
UO(9)
Bearish
51.16
ROC(12)
Uptrend But Slowing Down
3.43
WillR(14)
Neutral
-54.08

About Poly Medicure

Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more
Chairperson NameDevendra Raj Mehta